Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-28 23:44:35 - browse：55471

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Bernie brings in new pharma CEOs to talk drug prices

WSS

Nobel honors Karikó and Weissman's enduring partnership

The Karikó problem: Lessons for funding basic research

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Readout Newsletter: Amgen, Regeneron, BGI Group and more

The Biogen Aduhelm mess could happen again

hotspot

Wikipedia

Sign up for D.C. Diagnosis

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD: Venture capital, Gilead, and more M&A

State Dept. review finds Biden bears some blame for Afghanistan failures

RSV injection headlines need to be accurate for good uptake

Wildfire smoke exposes gaps in outdoor worker protections

RSV injection headlines need to be accurate for good uptake

Malaria cases in Florida and Texas: Here’s what you need to know

IVG is promising — but it won’t replace IVF quite yet

Virginia high school admissions case could be legal follow

CDC picks Alphabet's Verily for wasterwater surveillance contract

hotspot

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Johnson & Johnson sued for allegedly overpaying for workers' drugs

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Some top drug companies are starting to take action on climate

AstraZeneca stays mum on Medicare drug pricing negotiations

With Roe v Wade overturned, abortion providers work to adapt

hotspot

Wikipedia

hotspot

focus